Top Markets
Coin of the day
Cell Source, Inc. Cell Source, Inc.

Cell Source, Inc.

CLCS
Hisse Senetlerindeki Sıralama #28218
Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based... Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based therapies centered on regulating immune tolerance. The company's flagship innovation is its Veto Cell immune system management technology, an advanced immune tolerance platform capable of selectively suppressing specific immune responses. This Veto Cell technology finds application in numerous areas, including enhancing the acceptance of stem cell transplants for conditions like lymphoma, leukemia, and multiple myeloma. Furthermore, it is utilized in treating end-stage kidney disease, various other non-malignant organ diseases, and a spectrum of both cancerous and non-malignant illnesses. Founded in 2012, Cell Source, Inc. maintains its corporate headquarters in New York, New York.
Hisse Fiyatı
$0.4
Son senkronizasyon: 2026-10-02
Piyasa Değeri
$27.18M
Değişim (1 gün)
-14.88%
Değişim (1 yıl)
8.11%
Ülke
US
Ticaret Cell Source, Inc. (CLCS)

Kategori

Cell Source, Inc. (CLCS) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $0.43 - 2026-10-01

Gün sonu en düşük fiyat: $0.88 - 2014-05-01
Cell Source, Inc. için hisse fiyatı geçmişi: 2014 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) 57.71%
2025 -22.76%
2024 28.36%
2023 -41.25%
2022 -46.94%
2021 9.84%
2020 34.16%
2019 39.21%
2018 131.41%
2017 -37.38%
2016 -65.99%
2015 149.25%
2014 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$503.48 24.96%
US
$201.85 632.93%
US
$125.69 -7.66%
AU
$915.50 16.19%
NL
$767.59 9.52%
CH